Literature DB >> 19882355

Mitochondrial matters of the brain: amyloid formation and Alzheimer's disease introduction.

Peter L Pedersen1.   

Abstract

In recent years mitochondria, as the most abundant organelles in animal and human cells, have come to the forefront of biomedical research as they are now recognized not only as the major producers of ATP needed to drive cellular functions critical for life, but they are also the instruments of cell death. Not surprisingly, therefore, mitochondria are now known to be involved in many different diseases ranging from those that affect millions worldwide to those that affect only a few, i.e., rare diseases. These diseases include in addition to cardio-myopathies and cancer also diseases that affect many other organs/tissues including the brain/nervous system, the latter diseases now commonly referred to as "neurodegenerative diseases". Specifically, the subject of this mini-review series focuses on the role of mitochondria in Alzheimer's disease, a major age related neurodegenerative disease that results in loss or decline of memory and other cognitive abilities. This devastating disease affects millions of Americans, and globally multi-millions with very grim predictions for the future. Although the molecular and gene-related details that underlie Alzheimer's disease remain to be clearly elucidated, mitochondria appear to be very intimately involved. The purpose of this mini-review series is to summarize how various investigators working on this subject envision the role(s) of mitochondria in Alzheimer's disease. The development of future therapies for this disease is likely to rely heavily on the new knowledge gained.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19882355     DOI: 10.1007/s10863-009-9248-0

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  14 in total

Review 1.  Mitochondria: releasing power for life and unleashing the machineries of death.

Authors:  Donald D Newmeyer; Shelagh Ferguson-Miller
Journal:  Cell       Date:  2003-02-21       Impact factor: 41.582

2.  2009 Alzheimer's disease facts and figures.

Authors: 
Journal:  Alzheimers Dement       Date:  2009-05       Impact factor: 21.566

Review 3.  Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.

Authors:  Rukhsana Sultana; D Allan Butterfield
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

Review 4.  Role of mitochondrial-mediated signaling pathways in Alzheimer disease and hypoxia.

Authors:  Cristina Carvalho; Sónia C Correia; Renato X Santos; Susana Cardoso; Paula I Moreira; Timothy A Clark; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

Review 5.  The molecular and cellular pathogenesis of dementia of the Alzheimer's type an overview.

Authors:  Francisco A Luque; Stephen L Jaffe
Journal:  Int Rev Neurobiol       Date:  2009       Impact factor: 3.230

Review 6.  Is there a primary role of the mitochondrial genome in Alzheimer's disease?

Authors:  Michelangelo Mancuso; Valeria Calsolaro; Daniele Orsucci; Gabriele Siciliano; Luigi Murri
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

Review 7.  The role of cytochrome c oxidase deficiency in ROS and amyloid plaque formation.

Authors:  Alicia M Pickrell; Hirokazu Fukui; Carlos T Moraes
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

8.  Mitochondrial haplogroups associated with Japanese Alzheimer's patients.

Authors:  Shigeru Takasaki
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

Review 9.  Mitochondria and Alzheimer's disease: amyloid-beta peptide uptake and degradation by the presequence protease, hPreP.

Authors:  Nyosha Alikhani; Maria Ankarcrona; Elzbieta Glaser
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

Review 10.  Amino acids variations in amyloid-beta peptides, mitochondrial dysfunction, and new therapies for Alzheimer's disease.

Authors:  Hani Atamna
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

View more
  1 in total

Review 1.  Basic mechanisms of neurodegeneration: a critical update.

Authors:  Kurt A Jellinger
Journal:  J Cell Mol Med       Date:  2010-01-11       Impact factor: 5.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.